Literature DB >> 1378244

Age-related occurrence of signs and symptoms in the Rett syndrome.

I Witt Engerström1.   

Abstract

The occurrence of signs and symptoms in the Rett syndrome (RS) was analyzed in a series of females born 1945-87 (median age 17 1/2 years) and fulfilling the diagnostic criteria for classic RS. For general information, data from 91 girls and women were used (group A), while the more detailed analyses were based on three age related subgroups: the youngest 20, born 1980-87 (group B); the 34 girls born 1970-79 (group C); and the oldest 37, born 1945-69 (group D). Data from group A indicated a developmental stagnation (stage I) at median age 11 (5-24) months and loss of ability to use acquired skills (stage II) at 19 (12-36) months. Group B displayed subtle prodromes in the first months of life, and later in infancy gross motor delay with insufficient equilibrium control. Development invariably came to a definite break at a crucial stage of maturation and was followed by a remarkable "awakening" and return of interest to act and interact (stage III). Loss of skills belonged to the triad contact/communication, hand use/skill, and babble/words. By age 2 1/2 years, apraxia and involuntary and stereotyped movements, were found in all. Seizures, hyperventilation and spells of screams and laughter were more frequent in group C (94%, 65% and 71%, respectively), and breathholding, bloating and drooling in group D (73%, 43% and 81%, respectively). Plantar flexion and abiotrophy of feet, as well as peroneal weakness and scoliosis, increased with age and was found in 89%, 86%, and 89%, respectively. The sequence of events described, emerged as subtle insufficiency and more or less abruptly turned into loss. Conversely to known progressive encephalopathies, the deterioration was followed by excess of activity, only years later to turn into restriction.

Entities:  

Mesh:

Year:  1992        PMID: 1378244

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  7 in total

1.  Describing the phenotype in Rett syndrome using a population database.

Authors:  L Colvin; S Fyfe; S Leonard; T Schiavello; C Ellaway; N De Klerk; J Christodoulou; M Msall; H Leonard
Journal:  Arch Dis Child       Date:  2003-01       Impact factor: 3.791

2.  The role of GABAergic system in neurodevelopmental disorders: a focus on autism and epilepsy.

Authors:  Paola Sgadò; Mark Dunleavy; Sacha Genovesi; Giovanni Provenzano; Yuri Bozzi
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2011-09-09

3.  The relationship between MECP2 mutation type and health status and service use trajectories over time in a Rett syndrome population.

Authors:  Deidra Young; Ami Bebbington; Nick de Klerk; Carol Bower; Lakshmi Nagarajan; Helen Leonard
Journal:  Res Autism Spectr Disord       Date:  2011-01

Review 4.  MicroRNAs in psychiatric and neurodevelopmental disorders.

Authors:  Bin Xu; Maria Karayiorgou; Joseph A Gogos
Journal:  Brain Res       Date:  2010-04-10       Impact factor: 3.252

5.  Features of autism in Rett syndrome and severe mental retardation.

Authors:  Rebecca H Mount; Tony Charman; Richard P Hastings; Sheena Reilly; Hilary Cass
Journal:  J Autism Dev Disord       Date:  2003-08

6.  Unraveling Molecular Pathways Altered in MeCP2-Related Syndromes, in the Search for New Potential Avenues for Therapy.

Authors:  Alba-Aina Castells; Rafel Balada; Alba Tristán-Noguero; Mar O'Callaghan; Elisenda Cortès-Saladelafont; Ainhoa Pascual-Alonso; Àngels Garcia-Cazorla; Judith Armstrong; Soledad Alcántara
Journal:  Biomedicines       Date:  2021-02-03

7.  Clinical characteristics of children with rett syndrome.

Authors:  Zee-A Han; Ha Ra Jeon; Seong Woo Kim; Jin Young Park; Hee Jung Chung
Journal:  Ann Rehabil Med       Date:  2012-06-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.